132
Views
3
CrossRef citations to date
0
Altmetric
Review

Economic Evaluations of Interventions for Snakebites: A Systematic Review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 547-554 | Published online: 18 Sep 2020

References

  • World Health Organization (WHO). Snakebite envenoming. [Internet] 2019; 2019. Geneva: WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming.
  • Chippaux JP. Estimating the global burden of snakebite can help to improve management. PLoS Med. 2008;5:e221. doi:10.1371/journal.pmed.0050221
  • Gutiérrez JM, Williams D, Fan HW, Warrell DA. Snakebite envenoming from a global perspective: towards an integrated approach. Toxicon. 2010;56:1223–1235. doi:10.1016/j.toxicon.2009.11.020
  • Williams D, Gutiérrez JM, Harrison R, et al. The global snake bite initiative: an antidote for snake bite. Lancet. 2010;375:89–91. doi:10.1016/S0140-6736(09)61159-4
  • Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063. doi:10.1038/nrdp.2017.63
  • Gutiérrez JM, Theakston RD, Warrell DA. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med. 2006;3:e150. doi:10.1371/journal.pmed.0030150
  • Otero-Patiño R. Epidemiological, clinical and therapeutic aspects of Bothrops asper bites. Toxicon. 2009;54:998–1011. doi:10.1016/j.toxicon.2009.07.001
  • Vaiyapuri S, Vaiyapuri R, Ashokan R, et al. Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India. PLoS One. 2013;8:e80090. doi:10.1371/journal.pone.0080090
  • Seventy first World Health Assembly. Addressing the burden of snakebite envenoming. Available from: http://www.who.int/neglected_diseases/mediacentre/WHA_71.5_Eng.pdf?ua=1.
  • Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG, White J. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis. 2009;3:e569. doi:10.1371/journal.pntd.0000569
  • Weant KA, Bowers RC, Reed J, Braun KA, Dodd DM, Baker SN. Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012;32:433–440. doi:10.1002/j.1875-9114.2012.01026.x
  • Habib AG, Lamorde M, Dalhat MM, Habib ZG, Kuznik A, Lalloo DG. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. PLoS Negl Trop Dis. 2015;9:e3381. doi:10.1371/journal.pntd.0003381
  • Cardona-Arias JA, Higuita-Gutiérrez LF, Rios-Osorio LA. Revisiones Sistemáticas De La Literatura Científica: La Investigación Teórica Como Principio Para El Desarrollo De La Ciencia Básica y Aplicada. Bogotá: Ediciones Universidad Cooperativa de Colombia; 2016.
  • Qureshi H, Alam SE, Mustufa MA, Nomani NK, Asnani JL, Sharif M. Comparative cost and efficacy trial of Pakistani versus Indian anti snake venom. J Pak Med Assoc. 2013;63:1129–1132.
  • Hamza M, Idris MA, Maiyaki MB, et al. Cost-effectiveness of antivenoms for snakebite envenoming in 16 countries in West Africa. PLoS Negl Trop Dis. 2016;10:e0004568. doi:10.1371/journal.pntd.0004568
  • Kasturiratne A, Pathmeswaran A, Wickremasinghe AR, et al. The socio-economic burden of snakebite in Sri Lanka. PLoS Negl Trop Dis. 2017;11:e0005647. doi:10.1371/journal.pntd.0005647
  • Herzel BJ, Samuel SP, Bulfone TC, Raj CS, Lewin M, Kahn JG. Snakebite: an exploratory cost-effectiveness analysis of adjunct treatment strategies. Am J Trop Med Hyg. 2018;99:404–412. doi:10.4269/ajtmh.17-0922
  • Magalhães SFV, Peixoto HM, de Almeida Gonçalves Sachett J, et al. Snakebite envenomation in the Brazilian Amazon: a cost-of-illness study. Trans R Soc Trop Med Hyg. 2020;traa005. doi:10.1093/trstmh/traa005
  • Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5:e218. doi:10.1371/journal.pmed.0050218
  • Williams SS, Wijesinghe CA, Jayamanne SF, et al. Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl Trop Dis. 2011;5:e1255. doi:10.1371/journal.pntd.0001255
  • Mao YC, Liu PY, Chiang LC, et al. Naja atra snakebite in Taiwan. Clin Toxicol (Phila). 2018;56:273–280. doi:10.1080/15563650.2017.1366502
  • Kallel H, Mayence C, Houcke S, et al. Severe snakebite envenomation in French Guiana: when antivenom is not available. Toxicon. 2018;146:87–90. doi:10.1016/j.toxicon.2018.04.004
  • Johnston CI, Ryan NM, Page CB, et al. The Australian Snakebite project, 2005–2015 (ASP-20). The Australian. Med J Aust. 2017;207:119–125. doi:10.5694/mja17.00094
  • Gutiérrez JM, Rojas E, Quesada L, et al. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans R Soc Trop Med Hyg. 2005;99:468–475. doi:10.1016/j.trstmh.2004.09.014
  • Harrison RA, Casewell NR, Ainsworth SA, Lalloo DG. The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims. Trans R Soc Trop Med Hyg. 2019;113(12):835–838. doi:10.1093/trstmh/try134
  • Fox S, Rathuwithana AC, Kasturiratne A, Lalloo DG, de Silva HJ. Underestimation of snakebite mortality by hospital statistics in the Monaragala District of Sri Lanka. Trans R Soc Trop Med Hyg. 2006;100:693–695. doi:10.1016/j.trstmh.2005.09.003
  • Molesworth AM, Harrison R, Theakston RD, Lalloo DG. Geographic information system mapping of snakebite incidence in northern Ghana and Nigeria using environmental indicators: a preliminary study. Trans R Soc Trop Med Hyg. 2003;97:188–192. doi:10.1016/S0035-9203(03)90115-5
  • Rojas AM. Informe De Evento. Accidente Ofidico, Colombia, 2017. Bogotá: Instituto Nacional de Salud; 2018.
  • Temprano G, Aprea P, Dokmetjian JC. La producción pública de antivenenos en la Región de las Américas como factor clave en su accesibilidad. Rev Panam Salud Publica. 2017;41:1. doi:10.26633/RPSP.2017.109
  • Laing GD, Renjifo JM, Ruiz F, et al. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon. 2003;42:35–41. doi:10.1016/S0041-0101(03)00098-9
  • Visser LE, Kyei-Faried S, Belcher DW, Geelhoed DW, van Leeuwen JS, van Roosmalen J. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg. 2008;102:445–450. doi:10.1016/j.trstmh.2007.11.006
  • Herrera M, León G, Segura A, et al. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, Sheep and camel IgGs. Toxicon. 2005;46:775–781. doi:10.1016/j.toxicon.2005.08.004
  • Williams DJ, Gutierrez JM, Calvete JJ, et al. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. J Proteomics. 2011;74:1735–1767. doi:10.1016/j.jprot.2011.05.027
  • Calvete JJ, Arias AS, Rodríguez Y, et al. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: neutralization of toxic activities and antivenomics. Toxicon. 2016;119:280–288. doi:10.1016/j.toxicon.2016.06.022
  • Maria Gutierrez JM, Leon G, Lomonte B, Angulo Y. Antivenoms for snakebite envenomings. Inflamm Allergy Drug Targets. 2011;10:369–380. doi:10.2174/187152811797200669
  • Laustsen AH, María Gutiérrez J, Knudsen C, et al. Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon. 2018;146:151–175. doi:10.1016/j.toxicon.2018.03.004
  • Whitehead M, Dahlgren G. Concepts and principles for tackling social inequities in health: levelling up Part 1. In: Studies on Social and Economic Determinants of Population Health. Vol. 2. Copenhagen: WHO Regional Office for Europe; 2007:10–19.
  • Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–337. doi:10.3350/cmh.2014.20.4.327
  • Brown GC, Brown MM, Sharma S. Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm. 2003;11(3):157–170. doi:10.1076/ocii.11.3.157.17355
  • Zambrano A. Accidente ofídico como evento de interés en salud pública en Colombia: Aportes al diseño de estrategias de gestión. Bogotá: Universidad Nacional de Colombia; 2012.
  • Martins-Melo FR, Carneiro M, Ramos AN, Heukelbach J, Ribeiro ALP, Werneck GL. The burden of neglected tropical diseases in Brazil, 1990–2016: a subnational analysis from the global burden of disease study 2016. PLoS Negl Trop Dis. 2018;12:e0006559. doi:10.1371/journal.pntd.0006559
  • Deribew A, Kebede B, Tessema GA, et al. Mortality and disability-adjusted life-years (DALYs) for common neglected tropical diseases in Ethiopia, 1990–2015: evidence from the global burden of disease Study 2015. Ethiop Med J. 2017;55(Suppl 1):3–14.
  • Mitra AK, Mawson AR. Neglected tropical diseases: epidemiology and global burden. Trop Med Infect Dis. 2017;2:36.
  • Otero R, León G, Gutiérrez JM, et al. Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg. 2006;100:1173–1182. doi:10.1016/j.trstmh.2006.01.006